Patents by Inventor William C. Stallings

William C. Stallings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glyphosate resistant class I 5-endolpyruvylshikimate-3-phosphate synthase (EPSPS)
    Patent number: 8436159
    Abstract: The compositions and methods disclosed herein provide novel DNA molecules that encode glyphosate resistant EPSPS proteins and plants containing these new proteins. The plants that express the new EPSPS proteins are themselves tolerant to the herbicidal effects of glyphosate.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: May 7, 2013
    Assignee: Monsanto Technology LLC
    Inventors: Murtaza F. Alibhai, Claire Cajacob, Paul C. C. Feng, Gregory R. Heck, Youlin Qi, Stanislaw Flasinski, William C. Stallings
  • Glyphosate resistant class I 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS)
    Patent number: 7723575
    Abstract: The compositions and methods disclosed herein provide novel DNA molecules that encode glyphosate resistant EPSPS proteins and plants containing these new proteins. The plants that express the new EPSPS proteins are themselves tolerant to the herbicidal effects of glyphosate.
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: May 25, 2010
    Assignee: Monsanto Technology LLC
    Inventors: Murtaza F. Alibhai, Claire Cajacob, Paul C. C. Feng, Gregory R. Heck, Youlin Qi, Stanislaw Flasinski, William C. Stallings
  • Method of changing conformation of a matrix metalloproteinase
    Patent number: 6869951
    Abstract: The present invention provides a matrix metalloproteinase inhibiting compound having structure (VIII) or a salt, an enantiomer, a diastereomer, a racemate, or a tautomer thereof. In other embodiments, the present invention provides a method of changing the conformation of a matrix metalloproteinase, a method of inhibiting a matrix metal metalloproteinase, and a method of treating osteoarthritis.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: March 22, 2005
    Assignee: Pharmacia Corporation
    Inventors: William C. Stallings, Huey S. Shieh, Susan C. Howard, Gary A. DeCrescenzo, Joseph J. McDonald
  • Crystalline structure of human MAPKAP kinase-2
    Publication number: 20040005686
    Abstract: The crystal structure of human MAPKAP kinase-2 is described, including the high-resolution X-ray diffraction structure and atomic structure coordinates obtained therefrom. A method of crystallization of MK-2 involving the use of a crystallization additive and the specific empirical conditions involved in this crystallization method is also described. This method of crystallization allows a resolution of about 3 Angstroms to be achieved. The tertiary structure of this protein as determined by X-ray crystallography to a resolution of 3 Angstroms is shown. Also described are methods by which the atomic structural information obtained from the MK-2 crystals can be used to screen for, identify and/or design new drugs.
    Type: Application
    Filed: April 4, 2002
    Publication date: January 8, 2004
    Applicant: Pharmacia Corporation
    Inventors: Ravi G. Kurumbail, Jennifer L. Pawlitz, Roderick A. Stegeman, William C. Stallings, Huey S. Shieh, Robert J. Mourey, Suzanne L. Bolten, Richard M. Broadus
  • Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
    Patent number: 5633435
    Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.
    Type: Grant
    Filed: September 13, 1994
    Date of Patent: May 27, 1997
    Assignee: Monsanto Company
    Inventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings
  • Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
    Patent number: 5627061
    Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 6, 1997
    Assignee: Monsanto Company
    Inventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings
  • Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
    Patent number: RE39247
    Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: August 22, 2006
    Assignee: Monsanto Technology LLC
    Inventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings